Related Experiment Video
Updated: Mar 23, 2026
09:37
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
Published on: March 5, 2017
13.6K
New tools for experimental diabetes research: Cellular reprogramming and genome editing
1a Research Programs Unit, Molecular Neurology and Biomedicum Stem Cell Center , University of Helsinki, Children's Hospital .
Upsala Journal of Medical Sciences
|March 24, 2016
Summary
Human pluripotent stem cells offer a promising alternative for diabetes research, enabling the study of specific genetic factors and improving insulin secretion models. Genome editing tools like CRISPR/Cas9 enhance the functional maturation of stem cell-derived islets for future translational studies.
Area of Science:
- Endocrinology
- Stem Cell Biology
- Genetics
Background:
- Isolated human islets are scarce and limit diabetes research, especially for specific genotypes.
- Human pluripotent stem cells (hPSCs) can be differentiated into pancreatic cells, offering a renewable source.
- Current hPSC-derived islets exhibit immaturity, posing challenges for functional studies.
Purpose of the Study:
- To explore the potential of hPSCs in modeling diabetes and studying insulin secretion.
- To investigate the application of genome editing technologies for genotype-specific research.
- To assess the use of CRISPR/Cas9 for enhancing the maturation of stem cell-derived islets.
Main Methods:
- Generation of induced pluripotent stem cells (iPSCs) from somatic cells.
- Differentiation of iPSCs into pancreatic islet-like cells.
- Application of CRISPR/Cas9 for genome editing and transcriptional regulation.
Main Results:
- hPSC-derived islet-like cells can model developmental defects and improve insulin secretion studies.
- CRISPR/Cas9 enables the study of specific genotypes' impact on pancreatic cell function.
- Genome editing holds potential for improving the functional maturation of stem cell-derived islets.
Conclusions:
- hPSCs and genome editing are valuable tools for diabetes research, overcoming limitations of human islet scarcity.
- These technologies facilitate genotype-specific disease modeling and the study of insulin secretion.
- Advancements in stem cell differentiation and genome editing pave the way for translational diabetes research.
More Related Videos
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
01:28Forced Transdifferentiation
2.5K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.5K
01:22iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K